Bourne Partners is an international healthcare focused advisory firm. Unlike other generalist firms, we concentrate on providing world-class service and capital to middle-market healthcare companies around the globe. Specifically, we offer a complete range of financial advisory services to companies in the specialty pharmaceutical, medical device, biotechnology and service segments of the healthcare arena.

Our management team is composed of former healthcare executives and seasoned investment bankers who have experienced both the operating and transactional sides of the industry. We have meaningful expertise in the specifics of the international healthcare market and we bring this knowledge to bear for our clients. Our track record includes not only advising middle market companies in over $5 billion in financial advisory (M&A) assignments, but also growing companies into multimillion dollar pharmaceutical enterprises. We have assisted owners of private companies in mergers, acquisitions, partnering/development, and the sale or refinancing of businesses. We know the industry because we have been in the shoes of many of our clients as they consider various strategic alternatives. This knowledge makes our team uniquely positioned to provide advice based on true experience.